PCI Pharma Services Announces Completion of Biotech Center of Excellence in Philadelphia and Expansions to Biotech Capabilities in Europe
PCI Pharma Services (PCI) , a leading pharmaceutical and biopharmaceutical global outsourcing solutions provider, today announced the completion of the expansion of its new Biotech Center of Excellence in Philadelphia, Pennsylvania, a major investment that will represent the new U.S. biologics flagship site for customers.
- PCI Pharma Services (PCI) , a leading pharmaceutical and biopharmaceutical global outsourcing solutions provider, today announced the completion of the expansion of its new Biotech Center of Excellence in Philadelphia, Pennsylvania, a major investment that will represent the new U.S. biologics flagship site for customers.
- In addition, PCI is also announcing significant new investments to expand its global packaging capabilities for biologic drug products at its operations in Ireland, complementing existing capabilities in UK and Germany.
- These investments will provide customers with global packaging solutions for their biologics and injectable drug products to meet growing market demands.
- With these expansions, our Biotech Centers of Excellence are prepared to support the scale required to meet customers needs all over the world, said Brad Payne, chief operating officer, PCI Pharma Services.